These shares are ending the week positively. But why? The post Why Bowen Coal, Droneshield, Mesoblast, and St Barbara shares ...

Mesoblast Limited (AU:MSB) has released an update.Don't Miss Our Christmas Offers:Discover the latest stocks recommended by top Wall Street ...

Email Alerts for: Current price: $2.63 Market cap: $3.93bn Current price: $3.01 Current price: $2.31 Current price: $3.69 ...

If you thought crypto investors need to have strong stomachs, spare a thought for the investors who try their luck in the ...

Mesoblast (NASDAQ:MESO – Get Free Report) was downgraded by investment analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a research report issued on Monday, MarketBeat ...

Regenerative medicine company Mesoblast Ltd. received an early Christmas present from the FDA for approval of its allogeneic bone marrow-derived mesenchymal stromal cell (MSC) therapy, Ryoncil ...

Fintel reports that on December 23, 2024, Jefferies downgraded their outlook for Mesoblast Limited - Depositary Receipt () ...

Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, announced the Food and Drug Administration (FDA) approved Ryoncil (remestemcel-L) as the first mesenchymal ...

Jefferies downgraded Mesoblast (MESO) to Hold from Buy with a price target of A$2.30, up from A$1.10. The firm updated the company’s for the ...

GEN presents data compiled by Morningstar's Morningstar Direct asset management platform for StockWatch of the top five ...

Mesoblast Ltd (MESO) stock saw a modest uptick, ending the day at $16.76 which represents a slight increase of $4.51 or 36.82% from the prior close of $12.25. The stock opened at $18.68 and touched a ...

The local bourse hit a three-month low on Friday as CBA led banks down, Mesoblast gave back some of its gains and the ASX had ...